Detalhe da pesquisa
1.
Reducing unwarranted variation in care to improve health outcomes.
Healthc Financ Manage
; 70(11): 88-84, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29897221
2.
Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates.
Ann Clin Lab Sci
; 37(2): 141-7, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17522369
3.
Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents.
J Med Chem
; 46(14): 2973-84, 2003 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-12825937
4.
3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency.
J Med Chem
; 45(12): 2388-409, 2002 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-12036349
5.
Processive DNA synthesis observed in a polymerase crystal suggests a mechanism for the prevention of frameshift mutations.
Proc Natl Acad Sci U S A
; 100(7): 3895-900, 2003 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12649320
6.
Structure of mammalian protein geranylgeranyltransferase type-I.
EMBO J
; 22(22): 5963-74, 2003 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-14609943